OPDIVO 10 mg/mL concentrate for solution for infusion., Nivolumab/Relatlimab
CA224-047
Phase 3 small_molecule active
Quick answer
OPDIVO 10 mg/mL concentrate for solution for infusion., Nivolumab/Relatlimab for Previously Untreated Metastatic or Unresectable Melanoma is a Phase 3 program (small_molecule) at Bristol-Myers Squibb / Pfizer EEIG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bristol-Myers Squibb / Pfizer EEIG
- Indication
- Previously Untreated Metastatic or Unresectable Melanoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active